Search Results - "Gelderman, K.A."

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Advanced glycation end products (AGEs) and the soluble receptor for AGE (sRAGE) in patients with type 1 diabetes and coeliac disease by Bakker, S.F, Tushuizen, M.E, Gözütok, E, Çiftci, A, Gelderman, K.A, Mulder, C.J, Simsek, S

    “…Abstract Background and aims Advanced glycation end (AGE) products play a role in the progression of diabetic complications. Gluten-free diet (GFD) might…”
    Get full text
    Journal Article
  2. 2

    Complement component 4A protein levels are negatively related to frontal volumes in patients with schizophrenia spectrum disorders by Gangadin, S.S., Germann, M., de Witte, L.D., Gelderman, K.A., Mandl, R.C.W., Sommer, I.E.C.

    Published in Schizophrenia research (01-11-2023)
    “…Excessive C4A-gene expression may result in increased microglia-mediated synaptic pruning. As C4A overexpression is observed in schizophrenia spectrum…”
    Get full text
    Journal Article
  3. 3

    Membrane-bound complement regulatory proteins inhibit complement activation by an immunotherapeutic mAb in a syngeneic rat colorectal cancer model by Gelderman, K.A., Hakulinen, J., Hagenaars, M., Kuppen, P.J.K., Meri, S., Gorter, A.

    Published in Molecular immunology (01-09-2003)
    “…MAb-mediated immunotherapy offers a potential tool for destroying metastasizing colorectal tumor cells. Promising results have been obtained by using xenograft…”
    Get full text
    Journal Article
  4. 4

    CD55 expression patterns on intestinal neuronal tissue are divergent from the brain by Gelderman, K A, Zijlmans, H J M A A, Vonk, M J, Gorter, A

    Published in Gut (01-04-2004)
    “…Background and objectives: In this study, we investigated how enteric plexuses protect themselves from complement mediated attack. For this purpose, the…”
    Get full text
    Journal Article
  5. 5